Saumya Pandey
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: saumya pandey | Updated : December 24, 2023 2:01 PM IST
Phthalates, known endocrine disruptors present in various household products, have been linked to a reduced likelihood of conception, according to research from the University of Massachusetts Amherst. These chemicals, prevalent in items like shampoo, makeup, vinyl flooring, toys, and medical devices, enter the body through ingestion of food and liquids that have come in contact with phthalate-containing products.
Lead author Carrie Nobles and her team delved into data from the EAGeR study (Effects of Aspirin in Gestation and Reproduction), focusing on 1,228 participants attempting to conceive over six menstrual cycles. The study provided comprehensive information on menstrual cycles, ovulation timing, and pregnancy outcomes. Phthalate exposure was measured by analyzing 20 phthalate metabolites in urine samples taken at the study's onset.
The study identified a correlation between higher phthalate exposure and an extended time to pregnancy. Three specific parent compounds showed the strongest association with delayed conception. As phthalate exposure increased, so did the impact on fertility, suggesting a dose-dependent relationship.
Preconception exposure to phthalates was associated with alterations in women's reproductive hormones. Higher levels of phthalate exposure correlated with lower estradiol and higher follicle-stimulating hormone throughout the menstrual cycle. This hormonal profile aligns with characteristics seen in women with ovarian insufficiency, indicating potential disruptions in ovulation and early pregnancy establishment.
The research uncovered elevated levels of inflammation and oxidative stress in women with higher phthalate exposure. Increased C-reactive protein, a global marker of inflammation, was observed in correlation with higher phthalate levels. Inflammation and oxidative stress can lead to organ and tissue damage, posing risks to overall health. While women can opt for phthalate-free product alternatives, the pervasive nature of these chemicals makes individual exposure control challenging. In Europe, certain phthalates face restrictions, but the U.S. lacks formal prohibitions. The study's findings underscore the need for policy considerations and regulatory adjustments, emphasizing the negative impact of phthalate exposure on women's reproductive health.
The research contributes to the growing body of evidence highlighting the adverse effects of phthalate exposure on reproductive health. Carrie Nobles suggests a reevaluation of regulatory systems to identify and address exposures impacting fertility and healthy pregnancies. The findings serve as a call to action for increased awareness and policy measures to mitigate the impact of phthalates on women's reproductive well-being.
